27 EFFECT OF A SPECIFIC INHIBITOR OF DOT1L ON PREIMPLANTATION DEVELOPMENT OF PORCINE SOMATIC CLONED EMBRYOS

Abstract

EPZ004777 (EPZ), a specific inhibitor of DOT1L (a methyltransferase of H3K79), can significantly improve the generation and quality of mouse induced pluripotent stem cells [Onder et al. 2012 Nature 483(7391), 598–602), suggesting that H3K79 dimethylation (H3K79me2) is involved in controlling cell pluripotency. To date, however, it is unclear whether H3K79me2 regulates development competency of animal cloned embryos. Thus, we aimed to examine the dynamic changes of H3K79me2 in pre-implantation cloned embryos of pigs, and to explore effect of EPZ treatment of embryos on in vitro development fate in order to lay the foundation for revealing the role of H3K79me2 and mechanisms in controlling cell pluripotency. Porcine cloned embryos were treated immediately when fusion and activation stimuli were conducted, in vitro with porcine zygote medium (PZM)-3, including 0.5, 5, or 50 nM EPZ (S7353, Selleck Chemicals, Houston, TX, USA) and 1‰ DMSO (vol/vol, control group) for 24 h, respectively. Then, they were transferred into fresh PZM-3 without EPZ. We found that there was no significant difference in cleavage rate among groups, whereas the blastocyst rate of 0.5 nM EPZ group was higher than that of control group [28.97 ± 2.65% (28/96) v. 17.13 ± 2.69% (17/96)]. No obvious difference was observed for the total cell number of blastocyst among groups. We further treated the SCNT embryos with 0.5 nM EPZ for 0 (control group), 12, 24, and 36 h, respectively. No significant differences were found for cleavage rate among groups, whereas the blastocyst rates of the 12- and 24-h groups were significantly higher than that of control and 36-h groups [28.56 ± 3.51% (27/97), 28.34 ± 3.00% (25/88) v. 16.32 ± 1.93% (16/97), 17.93 ± 0.64% (18/100)]. Except for the remarkable decrease in the 36-h treatment group, no obvious difference was observed for the total cell number of blastocyst among the other 3 groups. All the above experiments were repeated at least 3 times. These results suggested that treatment of porcine SCNT embryos with 0.5 nM EPZ for 12 to 24 h could improve their development during the early stage. Then, we tested whether the EPZ favoured the in vitro development of porcine SCNT embryos by regulating H3K79me2 reprogramming. Porcine SCNT embryos were treated with 0.5 nM EPZ from the onset of electric activation and fusion stimuli was performed, and then the H3K79me2 signal (by immune-fluorescent staining) and expression of DOT1L (by RT-qPCR) at different development stages was analysed. We found that the H3K79me2 signal in control group (without EPZ treatment) decreased slowly from the time of electric stimulation to 4 hpa, and it disappeared in 8 hpa stage. In the EPZ treatment group, H3K79me2 signal started decreasing from 2 hpa, and disappeared in 8 hpa stage. The mRNA level of DOT1L in EPZ treatment group was lower than that in control group, although the difference was not significant. Taken together, treatment with EPZ at the appropriate concentration and for an appropriate time can improve the early in vitro development of pig SCNT embryos, probably by inhibiting expression of DOT1L and facilitating reprogramming of H3K79me2.

Research was supported by NSFC No. 31272442.